Brain tumor research in the United Kingdom: current perspective and future challenges. A strategy document from the NCRI Brain Tumor CSG
Kathreena M. Kurian(North Bristol NHS Trust), Colin Watts(Cancer Research UK Clinical Trials Unit), Sarah Jefferies(Addenbrooke's Hospital), Catherine McBain(Unknown), Samantha J. Mills(University of Manchester), Helen Bulbeck(Entrust), Peter Burchill, Alasdair G Rooney(MRC Centre for Regenerative Medicine), Adam Waldman(Royal Society of Edinburgh), Sara Erridge(The University of Texas MD Anderson Cancer Center), Michael D. Jenkinson(University of Liverpool), Paul M. Brennan(Radboud University Nijmegen), Debbie Keatley(CRUK Lung Cancer Centre of Excellence), Robin Grant(Western General Hospital), Erica Moyes(Brain Tumour Charity), Babar Vaqas(Imperial College Healthcare NHS Trust), Stephen J. Price(University of Cambridge), Martin G. McCabe(Manchester Academic Health Science Centre), W. Qian(Cambridge University Hospitals NHS Foundation Trust), Silvia Marino(Queen Mary University of London)
Cited by 12
Related Papers
The Multimodal Brain Tumor Image Segmentation Benchmark (BRATS)
|IEEE Transactions on Medical Imaging|2014|6.7k
Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial
|Journal of Clinical Oncology|2013|1.1k
Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial
|The Lancet Neurology|2008|774